Cajal Neuroscience

Cajal Neuroscience, which now operates publicly as Cajal Therapeutics, is a Seattle, Washington biotechnology company founded in 2020 by Alex Vaughan, Andrew Dervan and Ian Peikon, and launched in November 2022 with a $96 million Series A led by The Column Group and Lux Capital with participation from Two Sigma Ventures and Bristol Myers Squibb. The company develops small-molecule and RNA medicines that restore iron homeostasis, built around "iron mobilizers" — small molecules that transport iron across membranes into the compartments where it is required, bypassing disease-driven bottlenecks such as chronic inflammation, altered iron transporter expression and lysosomal dysfunction. Its pipeline spans systemic disease (CTX001, a clinical-stage iron mobilizer for anemia of chronic kidney disease; CTX201 and CTX211, preclinical siRNA programs for inflammatory anemia and myelofibrosis anemia) and CNS disease (a discovery-stage brain-penetrant iron mobilizer for Parkinson's disease). This is a therapeutics company, not a software or data platform company: it publishes no developer program, no public API, and no machine-readable API contract. Its public GitHub organization contains open-source laboratory hardware and firmware (a drone-motor spin coater, a microfluidic pressure sensor, a flow sensor) plus forks of third-party single-cell and genomics analysis tooling — none of which expose a network API.

Cajal Neuroscience is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Neurodegeneration.

Cajal Neuroscience’s developer surface includes product news and 8 more developer resources.

🌐 Visit website 📡 Source on GitHub
9.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyPharmaceuticalsDrug DiscoveryNeurodegenerationNeuroscienceTherapeuticsLife SciencesGenomicsHealth

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 9.1/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 1.8 / 17
Operational Transparency 0.6 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/cajal-neuroscience: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Cajal Neuroscience Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization
GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact
Contact

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 4

The organization behind the API

Website
Website
 News
News
 Careers
Careers
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: cajal-neuroscience
name: Cajal Neuroscience
description: 'Cajal Neuroscience, which now operates publicly as Cajal Therapeutics, is a Seattle, Washington biotechnology
  company founded in 2020 by Alex Vaughan, Andrew Dervan and Ian Peikon, and launched in November 2022 with a $96 million
  Series A led by The Column Group and Lux Capital with participation from Two Sigma Ventures and Bristol Myers Squibb. The
  company develops small-molecule and RNA medicines that restore iron homeostasis, built around "iron mobilizers" — small
  molecules that transport iron across membranes into the compartments where it is required, bypassing disease-driven bottlenecks
  such as chronic inflammation, altered iron transporter expression and lysosomal dysfunction. Its pipeline spans systemic
  disease (CTX001, a clinical-stage iron mobilizer for anemia of chronic kidney disease; CTX201 and CTX211, preclinical siRNA
  programs for inflammatory anemia and myelofibrosis anemia) and CNS disease (a discovery-stage brain-penetrant iron mobilizer
  for Parkinson''s disease). This is a therapeutics company, not a software or data platform company: it publishes no developer
  program, no public API, and no machine-readable API contract. Its public GitHub organization contains open-source laboratory
  hardware and firmware (a drone-motor spin coater, a microfluidic pressure sensor, a flow sensor) plus forks of third-party
  single-cell and genomics analysis tooling — none of which expose a network API.'
url: https://raw.githubusercontent.com/api-evangelist/cajal-neuroscience/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: no-api-surface
image: https://www.cajal-tx.com/apple-touch-icon.png
specificationVersion: '0.20'
created: '2026-08-08'
modified: '2026-08-08'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Neurodegeneration
- Neuroscience
- Therapeutics
- Life Sciences
- Genomics
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/cajal-neuroscience-domain-security.yml
- type: Website
  url: https://www.cajal-tx.com/
- type: GitHubOrganization
  url: https://github.com/CajalNeuroscience
- type: PrivacyPolicy
  url: https://www.cajal-tx.com/privacy
- type: News
  url: https://www.cajal-tx.com/news
- type: Contact
  url: https://www.cajal-tx.com/contact
- type: Careers
  url: https://www.cajal-tx.com/careers
- type: LinkedIn
  url: https://www.linkedin.com/company/cajal-tx/
- type: LLMsTxt
  url: llms/cajal-neuroscience-llms.txt
x-enrichment:
  date: '2026-08-08'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Cajal is a clinical-stage iron-homeostasis therapeutics company (CTX001 in Phase 1) whose only public engineering
    output is open-source lab-bench hardware — a drone-motor spin coater and two microfluidic sensors — so there is no product
    for an API to expose; cajalneuro.com 307-redirects to cajal-tx.com, and api./docs./developer./data.cajal-tx.com have no
    DNS record at all.
  evidence:
  - url: https://www.cajal-tx.com/openapi.json
    status: 404
  - url: https://www.cajal-tx.com/.well-known/agent-card.json
    status: 404
  - url: https://www.cajal-tx.com/.well-known/api-catalog
    status: 404
  - url: https://www.cajal-tx.com/llms.txt
    status: 404
  - url: https://api.github.com/orgs/CajalNeuroscience
    status: 200
  checked: '2026-08-08'